Impact Biomedical, Stock Performance
| IBO Stock | USD 0.46 0.04 8.00% |
The company retains a Market Volatility (i.e., Beta) of 0.29, which attests to not very significant fluctuations relative to the market. As returns on the market increase, Impact BioMedical,'s returns are expected to increase less than the market. However, during the bear market, the loss of holding Impact BioMedical, is expected to be smaller as well. At this point, Impact BioMedical, has a negative expected return of -0.38%. Please make sure to check out Impact BioMedical,'s potential upside, as well as the relationship between the daily balance of power and price action indicator , to decide if Impact BioMedical, performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Impact BioMedical, has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's fundamental drivers remain very healthy which may send shares a bit higher in January 2026. The recent disarray may also be a sign of long period up-swing for the firm investors. ...more
1 | Breakout Watch Will Impact BioMedical Inc. stock continue upward momentum - CEO Change AI Driven Stock Price Forecasts - fcp.pa.gov.br | 10/28/2025 |
2 | Why Impact BioMedical Inc. stock stays resilient - Earnings Overview Summary Community Verified Swing Trade Signals - newser.com | 11/05/2025 |
3 | Is Impact BioMedical Inc. stock trading near support levels - Bond Market Capital Protection Trading Alerts - newser.com | 11/12/2025 |
4 | Aug Final Week Why Impact BioMedical Inc. stock trades below fair value - Quarterly Market Review Fast Entry High Yield Stock Tips - B NI V | 12/01/2025 |
5 | Insider Trading | 12/26/2025 |
| Begin Period Cash Flow | 1438.00 | |
| Total Cashflows From Investing Activities | 2876.00 |
Impact BioMedical, Relative Risk vs. Return Landscape
If you would invest 67.00 in Impact BioMedical, on September 30, 2025 and sell it today you would lose (21.00) from holding Impact BioMedical, or give up 31.34% of portfolio value over 90 days. Impact BioMedical, is generating negative expected returns assuming volatility of 7.2639% on return distribution over 90 days investment horizon. In other words, 65% of stocks are less volatile than Impact, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Impact BioMedical, Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Impact BioMedical,'s investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Impact BioMedical,, and traders can use it to determine the average amount a Impact BioMedical,'s price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0518
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | IBO |
Based on monthly moving average Impact BioMedical, is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Impact BioMedical, by adding Impact BioMedical, to a well-diversified portfolio.
Impact BioMedical, Fundamentals Growth
Impact Stock prices reflect investors' perceptions of the future prospects and financial health of Impact BioMedical,, and Impact BioMedical, fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Impact Stock performance.
| Return On Equity | -3.47 | ||||
| Return On Asset | -0.0768 | ||||
| Operating Margin | (52.67) % | ||||
| Current Valuation | 75.05 M | ||||
| Shares Outstanding | 104.62 M | ||||
| Price To Book | 1.24 X | ||||
| Price To Sales | 2,085 X | ||||
| Revenue | 2.33 M | ||||
| Gross Profit | 23 K | ||||
| EBITDA | (1.54 M) | ||||
| Net Income | (35.53 M) | ||||
| Cash And Equivalents | 2 M | ||||
| Total Debt | 8.88 M | ||||
| Book Value Per Share | (0.97) X | ||||
| Cash Flow From Operations | (5.64 M) | ||||
| Earnings Per Share | (3.94) X | ||||
| Market Capitalization | 52.12 M | ||||
| Total Asset | 20.29 M | ||||
| Retained Earnings | (37.67 M) | ||||
| Working Capital | (7.34 M) | ||||
About Impact BioMedical, Performance
By examining Impact BioMedical,'s fundamental ratios, stakeholders can obtain critical insights into Impact BioMedical,'s financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Impact BioMedical, is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.74) | (0.78) | |
| Return On Capital Employed | 0.05 | 0.04 | |
| Return On Assets | (0.09) | (0.10) | |
| Return On Equity | (0.43) | (0.46) |
Things to note about Impact BioMedical, performance evaluation
Checking the ongoing alerts about Impact BioMedical, for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Impact BioMedical, help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Impact BioMedical, generated a negative expected return over the last 90 days | |
| Impact BioMedical, has high historical volatility and very poor performance | |
| Impact BioMedical, has some characteristics of a very speculative penny stock | |
| Impact BioMedical, has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the last year's revenue of 2.33 M. Reported Net Loss for the year was (35.53 M) with profit before taxes, overhead, and interest of 23 K. | |
| Impact BioMedical, has about 2 M in cash with (5.64 M) of positive cash flow from operations. | |
| Latest headline from news.google.com: Aug Final Week Why Impact BioMedical Inc. stock trades below fair value - Quarterly Market Review Fast Entry High Yield Stock Tips - B NI V |
- Analyzing Impact BioMedical,'s financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Impact BioMedical,'s stock is overvalued or undervalued compared to its peers.
- Examining Impact BioMedical,'s industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Impact BioMedical,'s management team can have a significant impact on its success or failure. Reviewing the track record and experience of Impact BioMedical,'s management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Impact BioMedical,'s stock. These opinions can provide insight into Impact BioMedical,'s potential for growth and whether the stock is currently undervalued or overvalued.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Impact BioMedical,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. To learn how to invest in Impact Stock, please use our How to Invest in Impact BioMedical, guide.You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Impact BioMedical,. If investors know Impact will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Impact BioMedical, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Impact BioMedical, is measured differently than its book value, which is the value of Impact that is recorded on the company's balance sheet. Investors also form their own opinion of Impact BioMedical,'s value that differs from its market value or its book value, called intrinsic value, which is Impact BioMedical,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Impact BioMedical,'s market value can be influenced by many factors that don't directly affect Impact BioMedical,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Impact BioMedical,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Impact BioMedical, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Impact BioMedical,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.